Market Place
Sourcing Support
KIMMTRAK Doubles 5-Year Survival in First-Line Uveal Melanoma
19 Apr 2026 //
GLOBENEWSWIRE
Immunocore Presents at 25th Needham Healthcare Conference
06 Apr 2026 //
GLOBENEWSWIRE
Immunocore Presents 5-Year KIMMTRAK Data at 2026 AACR Meeting
17 Mar 2026 //
GLOBENEWSWIRE
Immunocore To Present At Upcoming Investor Conferences
03 Mar 2026 //
GLOBENEWSWIRE
Immunocore To Report Q4 2025 Financials, Host Call On Feb 25
18 Feb 2026 //
GLOBENEWSWIRE
After R&D Head Exits, Immunocore CEO Pairs Ambition With Caution
13 Feb 2026 //
FIERCE BIOTECH
Immunocore Announces R&D Leadership Evolution
30 Jan 2026 //
GLOBENEWSWIRE
Immunocore Reveals 2026 Strategy At J.P. Morgan Healthcare Conf
09 Jan 2026 //
GLOBENEWSWIRE
Immunocore To Present At Upcoming Investor Conferences
10 Nov 2025 //
GLOBENEWSWIRE
Immunocore Unveils Hepatitis B Candidate Phase 1 Data at AASLD
07 Nov 2025 //
GLOBENEWSWIRE
Immunocore to present at upcoming investor conferences
04 Sep 2025 //
GLOBENEWSWIRE
Immunocore Reports Q2 Financial Results
07 Aug 2025 //
GLOBENEWSWIRE
Immunocore`s Q2 2025 Financial Results and Call on August 7, 2025
31 Jul 2025 //
GLOBENEWSWIRE
Er-Kim partners with Immunocore to distribute Kimmtrak in Turkey
30 Jun 2025 //
GLOBENEWSWIRE
Immunocore to present at 2025 Jefferies Healthcare Conference
02 Jun 2025 //
GLOBENEWSWIRE
Immunocore reports Q1 financial results and business update
07 May 2025 //
GLOBENEWSWIRE
Immunocore bispecific reduces HIV reservoir in early trial
11 Mar 2025 //
FIERCE BIOTECH
Immunocore to present at upcoming investor conferences
03 Mar 2025 //
GLOBENEWSWIRE
Immunocore To Report Q4, Full-Year 2024 Results On Feb 26
19 Feb 2025 //
GLOBENEWSWIRE
Immunocore to present at the 43rd Annual J.P. Morgan Conference
06 Jan 2025 //
GLOBENEWSWIRE
Immunocore Doses First Patient in Phase 1 IMC-P115C Trial
23 Dec 2024 //
GLOBENEWSWIRE
Immunocore 1st Patient in Ph 1/2 Trial of IMC-R117C for GI Cancers
17 Dec 2024 //
GLOBENEWSWIRE
Immunocore Announces KIMMTRAK? Reimbursement For Uveal Melanoma
02 Dec 2024 //
GLOBENEWSWIRE
Immunocore to present at upcoming investor conferences
08 Nov 2024 //
GLOBENEWSWIRE
Immunocore reports Q3 financial results & provides business update
06 Nov 2024 //
GLOBENEWSWIRE
Immunocore Presents Brenetafusp Phase 1 Data In Ovarian Cancer
14 Sep 2024 //
GLOBENEWSWIRE
Immunocore to present at the 2024 Cantor Global Healthcare Conference
12 Sep 2024 //
GLOBENEWSWIRE
Immunocore To Report Q2 2024 Results On August 8
01 Aug 2024 //
GLOBENEWSWIRE
Immunocore presents additional ctDNA data from KIMMTRAK Phase 3 trial at ASCO
03 Jun 2023 //
GLOBENEWSWIRE
Immunocore presents new KIMMTRAK data confirming association between early ctDNA
18 Apr 2023 //
GLOBENEWSWIRE
